{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(11)"],"submitter":["Chukwueke UN"],"funding":["National Institute of Neurological Disorders and Stroke","National Institutes of Health"],"pubmed_abstract":["<h4>Background</h4>Neuro-oncology has grown tremendously since 2010, marked by increasing society membership, specialized clinical expertise, and new journals. Yet, modest improvement in racial/ethnic diversity amongst clinical trial participants, researchers, and clinicians led us to conduct a survey to identify opportunities to enhance diversity and inclusiveness amongst neuro-oncology professionals.<h4>Methods</h4>In summer 2020, the Women and Diversity Committee of the Society for Neuro-Oncology (SNO) distributed an anonymous online survey to members and affiliates including the European Association of Neuro-Oncology (EANO), Asian Society for Neuro-Oncology (ASNO), Society for Neuro-Oncology Latin America (SNOLA) and Society for Neuro-Oncology Sub-Saharan Africa (SNOSSA). The survey ca"],"journal":["Neuro-oncology"],"pagination":["1845-1858"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8563326"],"repository":["biostudies-literature"],"pubmed_title":["SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology."],"pmcid":["PMC8563326"],"pubmed_authors":["Acquaye A","Jackson S","Vera E","Odia Y","Armstrong TS","Gatson NTN","Dunbar E","Camelo-Piragua S","Chukwueke UN","Sharma A","Thomas AA","Porter AB","Hervey-Jumper SL","Werbowetski-Ogilvie TE","Klesse LJ","Fonkem E","de la Fuente MI"],"additional_accession":[]},"is_claimable":false,"name":"SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology.","description":"<h4>Background</h4>Neuro-oncology has grown tremendously since 2010, marked by increasing society membership, specialized clinical expertise, and new journals. Yet, modest improvement in racial/ethnic diversity amongst clinical trial participants, researchers, and clinicians led us to conduct a survey to identify opportunities to enhance diversity and inclusiveness amongst neuro-oncology professionals.<h4>Methods</h4>In summer 2020, the Women and Diversity Committee of the Society for Neuro-Oncology (SNO) distributed an anonymous online survey to members and affiliates including the European Association of Neuro-Oncology (EANO), Asian Society for Neuro-Oncology (ASNO), Society for Neuro-Oncology Latin America (SNOLA) and Society for Neuro-Oncology Sub-Saharan Africa (SNOSSA). The survey ca","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Nov","modification":"2025-04-22T06:51:00.365Z","creation":"2025-04-05T21:55:33.83Z"},"accession":"S-EPMC8563326","cross_references":{"pubmed":["34302487"],"doi":["10.1093/neuonc/noab172"]}}